10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
JOHNSON & JOHNSON | |||
Ticker: JNJ Fiscal Year: 2021 | |||
Consolidated Statements of Earnings | |||
Period Ending Jan 2, 2022 10-K (Filed: Feb 17, 2022) | |||
(In Millions, except shares in Thousands) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Jan 2, 2022 | Jan 3, 2021 | Dec 29, 2019 | |
Sales to customers | $ 93,775 | 82,584 | 82,059 |
Cost of products sold | 29,855 | 28,427 | 27,556 |
Gross profit | 63,920 | 54,157 | 54,503 |
Selling, marketing and administrative expenses | 24,659 | 22,084 | 22,178 |
Research and development expense | 14,714 | 12,159 | 11,355 |
In-process research and development (Note 5) | 900 | 181 | 890 |
Interest income | (53) | (111) | (357) |
Interest expense, net of portion capitalized (Note 4) | 183 | 201 | 318 |
Other (income) expense, net | 489 | 2,899 | 2,525 |
Restructuring (Note 20) | 252 | 247 | 266 |
Earnings before provision for taxes on income | 22,776 | 16,497 | 17,328 |
Provision for taxes on income (Note 8) | 1,898 | 1,783 | 2,209 |
Net earnings | 20,878 | 14,714 | 15,119 |
Net earnings per share (Notes 1 and 15) | |||
Basic (in dollars per share) | 7.93 | 5.59 | 5.72 |
Diluted (in dollars per share) | 7.81 | 5.51 | 5.63 |
Average shares outstanding (Notes 1 and 15) | |||
Basic (in shares) | 2,632,100 | 2,632,800 | 2,645,100 |
Diluted (in shares) | 2,674,000 | 2,670,700 | 2,684,300 |
External Links | |
JOHNSON & JOHNSON (JNJ) Fiscal Year 2021 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |